Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| ZDRAVESKI ZORAN | See Remarks | 19 | $35.3K | $951.9K | 2026-10-01 |
| MacBeath Gavin | See Remarks | 10 | $31.1K | $0 | 2026-10-01 |
| Woods Keith | Director | 4 | $0 | $0 | 2026-05-20 |
| Gruia Gabriela | Director | 7 | $0 | $0 | 2026-05-20 |
| Klencke Barbara | Director | 9 | $108.0K | $0 | 2026-05-20 |
| Nicholson Garry A | Director | 4 | $0 | $0 | 2026-05-20 |
| Dorton Katina | Director | 5 | $0 | $0 | 2026-05-20 |
| 667, L.P. | Director, 10% Owner | 23 | $92.93M | $0 | 2026-05-20 |
| Louis Chrystal | Chief Medical Officer | 3 | $0 | $0 | 2026-01-20 |
| Dworak Leiden | See Remarks | 3 | $0 | $0 | 2026-01-20 |
| Amello Jason | Chief Financial Officer | 3 | $0 | $0 | 2026-01-20 |
| Lynx1 Capital Management LP | 10% Owner | 9 | $38.90M | $63.9K | 2025-12-23 |
| Nichols Weston | 10% Owner | 4 | $30.39M | $0 | 2024-12-26 |
| BAKER BROS. ADVISORS LP | Director | 4 | $0 | $0 | 2024-06-12 |
| BARBERICH TIMOTHY J | Director | 7 | $242.2K | $0 | 2023-12-19 |
| Barton Debora | Chief Medical Officer | 3 | $0 | $0 | 2023-06-13 |
| Silver Brian M. | Chief Financial Officer | 10 | $156.7K | $0 | 2023-06-13 |
| SOUTHWELL DAVID P | Chief Executive Officer | 8 | $185.8K | $0 | 2023-02-02 |
| Desmarais William | Chief Business Officer | 3 | $22.7K | $0 | 2022-07-25 |
| Harel Ittai | Director | 1 | $0 | $0 | 2022-06-01 |
| Westphal Christoph H | 10% Owner | 5 | $2.00M | $0 | 2021-07-20 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ZDRAVESKI ZORAN | See Remarks | A Award | 2026-10-01 | 2026-10-02 | 300,000 | — | $0 | 304,716 | SEC↗ |
| MacBeath Gavin | Chief Executive Officer, Dir | A Award | 2026-10-01 | 2026-10-02 | 1,000,000 | — | $0 | 1,049,767 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Dorton Katina | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | A Award deriv | 2026-01-20 | 2026-01-22 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Louis Chrystal | Chief Medical Officer | A Award deriv | 2026-01-20 | 2026-01-22 | 420,000 | — | $0 | 420,000 | SEC↗ |
| Dworak Leiden | See Remarks | A Award deriv | 2026-01-20 | 2026-01-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MacBeath Gavin | Chief Executive Officer | A Award deriv | 2026-01-20 | 2026-01-22 | 1,165,000 | — | $0 | 1,165,000 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award deriv | 2026-01-20 | 2026-01-22 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-12-23 | 2025-12-23 | 6,232 | $0.90 | $5.6K | 8,019,148 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-12-22 | 2025-12-23 | 75,500 | $0.90 | $68.0K | 8,012,916 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-12-19 | 2025-12-23 | 80,069 | $0.90 | $72.1K | 7,937,416 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Dorton Katina | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-05-20 | 2025-05-21 | 1,200,000 | $1.20 | $1.44M | 7,946,141 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy | 2025-05-19 | 2025-05-21 | 1,388,794 | $1.20 | $1.67M | 6,746,141 | SEC↗ |
| Louis Chrystal | Chief Medical Officer | A Award deriv | 2025-01-03 | 2025-02-11 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award deriv | 2025-01-03 | 2025-02-11 | 270,000 | — | $0 | 270,000 | SEC↗ |
| MacBeath Gavin | Chief Executive Officer | A Award deriv | 2025-01-03 | 2025-02-11 | 800,000 | — | $0 | 800,000 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | A Award deriv | 2025-01-03 | 2025-02-11 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Nichols Weston | 10% Owner | P Buy deriv | 2024-12-26 | 2024-12-30 | 7,500,000 | $4.00 | $30.00M | 7,500,000 | SEC↗ |
| Nichols Weston | 10% Owner | P Buy | 2024-12-13 | 2024-12-16 | 100,000 | $2.90 | $290.0K | 5,357,347 | SEC↗ |
| Nichols Weston | 10% Owner | P Buy | 2024-12-12 | 2024-12-16 | 31,800 | $3.01 | $95.7K | 5,257,347 | SEC↗ |
| Nichols Weston | 10% Owner | P Buy | 2024-11-15 | 2024-11-19 | 947 | $4.34 | $4.1K | 5,225,547 | SEC↗ |
| Klencke Barbara | Director | P Buy | 2024-09-23 | 2024-09-24 | 5,000 | $5.29 | $26.4K | 45,000 | SEC↗ |
| Klencke Barbara | Director | P Buy | 2024-08-26 | 2024-08-27 | 5,000 | $5.53 | $27.6K | 40,000 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2024-08-23 | 2024-08-27 | 13,125 | — | $0 | 21,875 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2024-08-23 | 2024-08-27 | 54,895 | — | $0 | 30,105 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2024-08-23 | 2024-08-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise deriv | 2024-08-23 | 2024-08-27 | 64,166 | — | $0 | 365,834 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2024-08-23 | 2024-08-27 | 54,895 | $4.85 | $266.2K | 67,111 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2024-08-23 | 2024-08-27 | 25,000 | $3.27 | $81.8K | 92,111 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2024-08-23 | 2024-08-27 | 13,125 | $1.81 | $23.8K | 105,236 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | M Exercise | 2024-08-23 | 2024-08-27 | 64,166 | $2.49 | $159.8K | 169,402 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | S Sale | 2024-08-23 | 2024-08-27 | 164,686 | $5.78 | $951.9K | 4,716 | SEC↗ |
| Klencke Barbara | Director | P Buy | 2024-08-23 | 2024-08-27 | 5,000 | $5.69 | $28.5K | 35,000 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Nicholson Garry A | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 23,750 | — | $0 | 23,750 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Dorton Katina | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Louis Chrystal | Chief Medical Officer | A Award deriv | 2024-05-01 | 2024-05-03 | 380,000 | — | $0 | 380,000 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | P Buy deriv | 2024-04-19 | 2024-04-23 | 5,000,000 | $7.13 | $35.65M | 5,000,000 | SEC↗ |
| 667, L.P. | Director | P Buy deriv | 2024-04-19 | 2024-04-23 | 8,851,451 | $7.13 | $63.11M | 43,158,741 | SEC↗ |
| 667, L.P. | Director | P Buy deriv | 2024-04-19 | 2024-04-23 | 825,968 | $7.13 | $5.89M | 4,018,678 | SEC↗ |
| Amello Jason | Chief Financial Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 750,000 | — | $0 | 750,000 | SEC↗ |
| MacBeath Gavin | Chief Executive Officer | A Award deriv | 2024-01-12 | 2025-02-11 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Dworak Leiden | Other | A Award deriv | 2024-01-12 | 2025-02-11 | 46,875 | — | $0 | 46,875 | SEC↗ |
| ZDRAVESKI ZORAN | See Remarks | A Award deriv | 2024-01-12 | 2025-02-11 | 52,500 | — | $0 | 52,500 | SEC↗ |
| BARBERICH TIMOTHY J | Director | P Buy | 2023-12-19 | 2023-12-21 | 317 | $4.97 | $1.6K | 67,027 | SEC↗ |
| BARBERICH TIMOTHY J | Director | P Buy | 2023-12-18 | 2023-12-21 | 28,830 | $4.89 | $141.0K | 66,710 | SEC↗ |
| Klencke Barbara | Director | P Buy | 2023-12-14 | 2023-12-18 | 5,000 | $5.08 | $25.4K | 30,000 | SEC↗ |
| Woods Keith | Director | A Award deriv | 2023-12-06 | 2023-12-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Dworak Leiden | Chief Accounting Officer | A Award deriv | 2023-07-21 | 2023-07-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ZDRAVESKI ZORAN | Chief Legal Officer | A Award deriv | 2023-06-13 | 2023-06-15 | 430,000 | — | $0 | 430,000 | SEC↗ |
| MacBeath Gavin | Chief Executive Officer | A Award deriv | 2023-06-13 | 2023-06-15 | 1,121,300 | — | $0 | 1,121,300 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | A Award deriv | 2023-06-13 | 2023-06-15 | 632,500 | — | $0 | 632,500 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 36,524 | — | $0 | 36,524 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Dorton Katina | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Barton Debora | Chief Medical Officer | A Award deriv | 2023-06-13 | 2023-06-15 | 430,000 | — | $0 | 430,000 | SEC↗ |
| BARBERICH TIMOTHY J | Director | A Award deriv | 2023-06-13 | 2023-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BARBERICH TIMOTHY J | Director | P Buy | 2023-06-02 | 2023-06-06 | 37,880 | $2.63 | $99.6K | 37,880 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 34,307,290 | $2.00 | $68.61M | 34,307,290 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 3,192,710 | $2.00 | $6.39M | 3,192,710 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | S Sale | 2023-05-31 | 2023-06-02 | 15,000 | $2.52 | $37.8K | 5,225,000 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | S Sale | 2023-05-31 | 2023-06-02 | 10,000 | $2.51 | $25.1K | 5,240,000 | SEC↗ |
| Lynx1 Capital Management LP | 10% Owner | S Sale | 2023-05-31 | 2023-06-02 | 400 | $2.51 | $1.0K | 5,224,600 | SEC↗ |
| Klencke Barbara | Director | A Award deriv | 2023-04-06 | 2023-04-10 | 9,146 | — | $0 | 9,146 | SEC↗ |
| Barton Debora | Chief Medical Officer | A Award deriv | 2023-02-02 | 2023-02-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MacBeath Gavin | See Remarks | A Award deriv | 2023-02-02 | 2023-02-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | A Award deriv | 2023-02-02 | 2023-02-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ZDRAVESKI ZORAN | Chief Legal Officer | A Award deriv | 2023-02-02 | 2023-02-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | P Buy | 2022-12-28 | 2022-12-29 | 3,158 | $1.56 | $4.9K | 32,885 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | P Buy | 2022-12-27 | 2022-12-29 | 2,842 | $1.50 | $4.3K | 29,727 | SEC↗ |
| MacBeath Gavin | See Remarks | A Award deriv | 2022-07-25 | 2022-07-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | A Award deriv | 2022-07-25 | 2022-07-27 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ZDRAVESKI ZORAN | Chief Legal Officer | A Award deriv | 2022-07-25 | 2022-07-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Desmarais William | Chief Business Officer | A Award deriv | 2022-07-25 | 2022-07-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | A Award deriv | 2022-07-25 | 2022-07-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Barton Debora | Chief Medical Officer | A Award deriv | 2022-07-05 | 2022-07-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Harel Ittai | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 9,146 | — | $0 | 9,146 | SEC↗ |
| Dorton Katina | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 9,146 | — | $0 | 9,146 | SEC↗ |
| BARBERICH TIMOTHY J | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 9,146 | — | $0 | 9,146 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 9,146 | — | $0 | 9,146 | SEC↗ |
| 667, L.P. | Director, 10% Owner | A Award deriv | 2022-06-01 | 2022-06-03 | 9,146 | — | $0 | 9,146 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | P Buy | 2022-05-18 | 2022-05-20 | 10,000 | $3.55 | $35.5K | 171,569 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | P Buy | 2022-05-18 | 2022-05-20 | 15,000 | $3.62 | $54.3K | 161,569 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-11 | 2022-05-12 | 2,882 | $1.99 | $5.7K | 256,209 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-11 | 2022-05-12 | 22,983 | $1.99 | $45.7K | 2,528,583 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 101,831 | $1.93 | $196.5K | 1,747,506 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 40,800 | $1.70 | $69.4K | 145,498 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 758,094 | $1.95 | $1.48M | 2,505,600 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 95,060 | $1.95 | $185.4K | 253,327 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 12,769 | $1.93 | $24.6K | 158,267 | SEC↗ |
| 667, L.P. | Director, 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 325,373 | $1.70 | $553.1K | 1,645,675 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | P Buy | 2022-03-24 | 2022-03-28 | 15,000 | $3.40 | $51.0K | 26,885 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 275,000 | — | $0 | 275,000 | SEC↗ |
| ZDRAVESKI ZORAN | Chief Legal Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 115,000 | — | $0 | 115,000 | SEC↗ |
| MacBeath Gavin | Chief Scientific Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Desmarais William | Chief Business Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | M Exercise deriv | 2021-12-23 | 2021-12-27 | 48,670 | — | $0 | 21,161 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | M Exercise | 2021-12-23 | 2021-12-27 | 48,670 | $1.97 | $95.9K | 146,569 | SEC↗ |
| ZDRAVESKI ZORAN | Chief Legal Officer | P Buy | 2021-09-23 | 2021-09-27 | 4,716 | $7.48 | $35.3K | 4,716 | SEC↗ |
| MacBeath Gavin | Chief Scientific Officer | P Buy | 2021-09-21 | 2021-09-22 | 57 | $6.19 | $353 | 49,767 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | P Buy | 2021-09-21 | 2021-09-22 | 5,000 | $6.32 | $31.6K | 11,885 | SEC↗ |
| MacBeath Gavin | Chief Scientific Officer | P Buy | 2021-09-20 | 2021-09-22 | 4,943 | $6.22 | $30.7K | 49,710 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | P Buy | 2021-09-09 | 2021-09-13 | 5,885 | $8.48 | $49.9K | 6,885 | SEC↗ |
| SOUTHWELL DAVID P | Chief Executive Officer | P Buy | 2021-09-08 | 2021-09-09 | 11,000 | $8.73 | $96.0K | 97,899 | SEC↗ |
| ZDRAVESKI ZORAN | Chief Legal Officer | A Award deriv | 2021-09-07 | 2021-09-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Desmarais William | Chief Business Officer | P Buy | 2021-08-27 | 2021-08-31 | 2,500 | $9.08 | $22.7K | 2,500 | SEC↗ |
| BARBERICH TIMOTHY J | Director | C Conversion deriv | 2021-07-20 | 2021-07-22 | 33,259 | — | $0 | 0 | SEC↗ |
| 667, L.P. | Director | C Conversion deriv | 2021-07-20 | 2021-07-22 | 315,777 | — | $0 | 315,777 | SEC↗ |
| 667, L.P. | Director | C Conversion deriv | 2021-07-20 | 2021-07-22 | 3,960,811 | — | $0 | 0 | SEC↗ |
| 667, L.P. | Director | C Conversion deriv | 2021-07-20 | 2021-07-22 | 3,960,811 | — | $0 | 3,960,811 | SEC↗ |
| 667, L.P. | Director | C Conversion deriv | 2021-07-20 | 2021-07-22 | 315,777 | — | $0 | 0 | SEC↗ |
| Westphal Christoph H | 10% Owner | C Conversion deriv | 2021-07-20 | 2021-07-22 | 332,594 | — | $0 | 0 | SEC↗ |
| Westphal Christoph H | 10% Owner | C Conversion deriv | 2021-07-20 | 2021-07-22 | 171,063 | — | $0 | 0 | SEC↗ |
| Westphal Christoph H | 10% Owner | C Conversion deriv | 2021-07-20 | 2021-07-22 | 641,848 | — | $0 | 0 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | P Buy | 2021-07-20 | 2021-07-22 | 1,000 | $15.00 | $15.0K | 1,000 | SEC↗ |
| BARBERICH TIMOTHY J | Director | C Conversion | 2021-07-20 | 2021-07-22 | 33,259 | — | $0 | 33,259 | SEC↗ |
| 667, L.P. | Director | P Buy | 2021-07-20 | 2021-07-22 | 1,320,302 | $15.00 | $19.80M | 1,320,302 | SEC↗ |
| 667, L.P. | Director | P Buy | 2021-07-20 | 2021-07-22 | 104,698 | $15.00 | $1.57M | 104,698 | SEC↗ |
| Westphal Christoph H | 10% Owner | P Buy | 2021-07-20 | 2021-07-22 | 133,333 | $15.00 | $2.00M | 1,278,838 | SEC↗ |
| Westphal Christoph H | 10% Owner | C Conversion | 2021-07-20 | 2021-07-22 | 1,145,505 | — | $0 | 1,145,505 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 9,146 | — | $0 | 9,146 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2021-07-15 | 2021-07-16 | 9,146 | — | $0 | 9,146 | SEC↗ |
| Silver Brian M. | Chief Financial Officer | A Award deriv | 2021-07-15 | 2021-07-16 | 250,441 | — | $0 | 250,441 | SEC↗ |